Precigen stockholders approve 7M share increase for 2023 Omnibus Incentive Plan at annual meeting

PRECIGEN, INC.

All nine director nominees elected; Randal Kirk received 207,060,147 votes for, 5,072,069 against.
Ratification of Deloitte & Touche as auditor: 272,813,907 for, 253,969 against.
Non-binding advisory say-on-pay approved: 208,241,739 for, 2,790,879 against.
2023 Plan Amendment No. 3 (7M additional shares) approved: 207,056,264 for, 4,996,260 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.